NEUTROPHIL - LYMPHOCYTE RATIO AS AN ANTICIPATORY FACTOR IN THE PROGNOSIS OF MORTALITY AND SEVERITY IN COVID-19 PATIENTS

Document Type : Preliminary preprint short reports of original research

Authors

1 Department of Chest Diseases, Chest Diseases, Faculty of Medicine, Alexandria University.

2 Department of Clinical and Chemical Pathology, Faculty of Medicine Alexandria University

3 Department of emergency medicine,faculty of medicine Alexandria university,Egypt

4 Department of Emergency Medicine, Emergency Medicine, Faculty of Medicine, Alexandria University.

Abstract

The national Institute of fitness of China in 2019 informed the world health organization (WHO) to several cases of pneumonia in Wuhan, China. Several cases have been infected with Coronavirus, and the virus was named by WHO as Coronavirus disease 2019 (Covid-19). At the middle of January 2020, around seven thousand cases and twelve thousand suspected cases were reported in China, and 80 confirmed instances had been observed in about twenty different international locations.WHO declared that SARS-CoV-2 is an epidemic condition and a public outbreak.
Different laboratory investigations have been proposed for the early detection, and identification of patients who were affected with SARS-CoV-2 virus, including decrease lymphocytic count, prolonged prothrombin time. Different cases have shown to have an increase of inflammatory markers, including: C-reactive protein, creatinine kinase, and prolactin levels.
Aim of the Work
The primary aim of this study was to evaluate Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 PCR positive patients. The secondary aim of this study is looking for various parameters related to worsening outcomes.

Keywords

ALEXMED ePosters
Volume 5, Issue 1
January 2023
Pages 18-19

Files

Share

How to cite

Statistics